$59.780
-2.756 (-4.61%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ETON Prediction & Forecast by Similar Chart Analysis
Alphio's ETON stock price prediction model matches the current Eton Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $59.57 (-0.35%). The 1-week path is $61.76 (+3.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Eton Pharmaceuticals Inc Stock?
Eton Pharmaceuticals is a good buy right now due to its strong recent earnings performance and growth trajectory. The stock is currently priced at $59.78, with a forward P/E of 46.30, suggesting that while it is valued at a premium, the growth potential justifies this. Additionally, the gross margin has improved significantly to 67.61% in Q2 2026, reflecting strong operational efficiency. However, a risk to consider is the recent insider selling, where a director sold 50,000 shares, which may signal caution about future performance.
ETON stock price ended at $59.78 on Friday, after losing -4.61%
Eton Pharmaceuticals Inc (ETON) last closed at $59.78, losing -4.61%. These facts feed the 1-day and 1-week ETON price prediction above.
Forecast Drivers
Eton Pharmaceuticals Inc (ETON) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ETON, ranked by similarity.
Seasonality analysis for ETON
Historically the probability of a positive August return for ETON is 68.25%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ETON
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $26.64 | $29.96 | $35.25 | -49.88% |
| Sep 2026 | $33.57 | $36.50 | $39.63 | -38.95% |
| Oct 2026 | $33.38 | $37.59 | $43.15 | -37.12% |
| Nov 2026 | $33.97 | $36.87 | $38.90 | -38.32% |
| Dec 2026 | $28.63 | $32.75 | $35.05 | -45.22% |
In 2026, Eton Pharmaceuticals Inc (ETON) is projected to range from $26.64 to $43.15.
Eton Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Eton Pharmaceuticals Inc is projected to average $29.96, with a low of $26.64 and high of $35.25.
In Sep 2026, Eton Pharmaceuticals Inc is projected to average $36.50, with a low of $33.57 and high of $39.63.
In Oct 2026, Eton Pharmaceuticals Inc is projected to average $37.59, with a low of $33.38 and high of $43.15.
In Nov 2026, Eton Pharmaceuticals Inc is projected to average $36.87, with a low of $33.97 and high of $38.90.
In Dec 2026, Eton Pharmaceuticals Inc is projected to average $32.75, with a low of $28.63 and high of $35.05.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.